FDA Registration
Active
🇰🇷 South Korea
Mygen V-1000 RF Generator
Reg #: 3015136673
·
FEI: 3015136673
·
Expires 2025
Products
1
Proprietary Names
34
Establishment Types
2
Classifications
1
Registration Details
- Registration Name
- RF MEDICAL CO., LTD
- Registration Number
- 3015136673
- FEI Number
- 3015136673
- Status
- Active
- Expiry Year
- 2025
- Initial Importer
- No
- Address
- #502~#507,#511,#601, 254 Beotkkot-ro, Geumcheon-gu
- City
- Seoul
- Country
- KR
Regulatory Submissions
- 510(k) Number
- K180999
Owner / Operator
- Firm Name
- RF MEDICAL CO., LTD
- Operator Number
- 10059293
- Address
- #502~#507,#511,#601, 254 Beotkkot-ro, Geumcheon-gu
- City
- Seoul
- State
- KR-11
- Postal Code
- 08513
- Country
- KR
- Correspondent
- Kwang Sun Choi
US Agent
- Business Name
- Mtech Group LLC
- Contact Name
- Dave Kim
- Address
- 7505 Fannin St. Suite 610
- City
- Houston
- State
- TX
- ZIP
- 77054
- Country
- US
- [email protected]
- Phone
- 713 4672607
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Electrosurgical, Cutting & Coagulation & Accessories | GEI | Class 2 | General, Plastic Surgery | No | 2018-12-18 |
Proprietary Names
Mygen V-1000 RF Generator
THYBLATE (RFTS 07XXLN)
THYBLATE (RFTS 07XX)
THYBLATE (RFTSP 10XXN)
THYBLATE (RFT 07XXN)
THYBLATE (RFT 07XXL)
THYBLATE (RFT 07XXHLN)
THYBLATE (RFTP 10XXN)
THYBLATE (RFT 07XXHN)
THYBLATE (RFTP 07XXHN)
THYBLATE (RFTSP 07XXLN)
THYBLATE (RFT 10XXHLN)
THYBLATE (RFTP 10XXHLN)
THYBLATE (RFT 10XXLN)
THYBLATE (RFTP 07XXN)
THYBLATE (RFTSP 07XXN)
THYBLATE (RFT 10XXL)
THYBLATE (RFT 07XXLN)
THYBLATE (RFT 10XXHL)
THYBLATE (RFTP 10XXLN)
THYBLATE (RFT 07XX)
THYBLATE (RFTS 07XXL)
THYBLATE (RFTP 07XXLN)
THYBLATE (RFTP 10XXHL)
THYBLATE (RFTS 07XXN)
THYBLATE (RFT 10XXN)
THYBLATE (RFT 10XX)
THYBLATE (RFTP 10XXHN)
THYBLATE (RFT 07XXHL)
THYBLATE (RFT 07XXH)
THYBLATE (RFTP 07XXHL)
THYBLATE (RFTP 07XXHLN)
THYBLATE (RFT 10XXHN)
THYBLATE (RFTSP 10XXLN)
Establishment Types
Manufacture Medical Device
Complaint File Establishment per 21 CFR 820.198